首页> 外文期刊>Renal failure. >Effect of gradually lowering dialysate sodium concentration on the interdialytic weight gain, blood pressure, and extracellular water in anuric hemodialysis patients
【24h】

Effect of gradually lowering dialysate sodium concentration on the interdialytic weight gain, blood pressure, and extracellular water in anuric hemodialysis patients

机译:逐渐降低透析液钠浓度对无尿血液透析患者透析间增重,血压和细胞外水的影响

获取原文
           

摘要

Background: The majority of hemodialysis (HD) patients are overhydrated and have high interdialytic weight gain (IDWG) which induces increased blood pressure (BP). The positive sodium balance resulting from a high sodium diet, a high dialysate sodium concentration (DNa), or a combination of both is major causes of this disease. We evaluated the effects of lowering DNa on IDWG, BP, and volume status in anuric HD patients with dietary sodium restriction. Methods: Thirty-two patients were enrolled in this study and the period was divided by phase 1 and 2 according to DNa which decreased from 140 to 135 mEq/L at a rate of 1 mEq/L per month; phase 1, 140 mEq/L; phase 2, 135 mEq/L. We compared the IDWG, BP, volume status measured by multifrequency bioimpedance spectroscopy, and adverse events such as intradialytic hypotension, cramps, and headache of both phases. Results: The IDWG was significantly reduced by 0.39?±?0.38?kg (p?=?0.000). Pre-dialysis BP showed significant reduction (systolic pressure 146?±?18 vs. 138?±?22?mmHg; p?=?0.012, diastolic pressure 80?±?10 vs. 75?±?11?mmHg; p?=?0.008). Pre-dialysis extracellular water (ECW) was reduced significantly by 0.13?±?2.22 L (p?=?0.02). There was no significant increase in adverse events (all p?>?0.05). Conclusions: This study showed that gradually lowering DNa could bring a significant reduction in pre-dialysis IDWG, BP, and ECW without increased adverse events. Large and crossover designed study will be needed to demonstrate the clear causal relationship.
机译:背景:大多数血液透析(HD)患者水分过多,透析间增重(IDWG)高,从而导致血压(BP)升高。高钠饮食,高透析液钠浓度(DNa)或二者兼而有之,导致钠平衡的正平衡是造成该疾病的主要原因。我们评估了降低DNa对饮食性钠盐限制的无尿HD患者IDWG,BP和体积状态的影响。方法:本研究招募了32例患者,根据Dna分为1期和2期,其Dna从140降至135 mEq / L,每月减少1 mEq / L。第一阶段,140 mEq / L;第二阶段135 mEq / L。我们比较了IDWG,BP,通过多频生物阻抗谱测量的体积状态以及诸如透析内低血压,痉挛和两相头痛等不良事件。结果:IDWG显着降低了0.39?±?0.38?kg(p?=?0.000)。透析前的BP显着降低(收缩压146±±18 vs.138±±22?mmHg; p?=?0.012,舒张压80±±10 vs. 75?±?11?mmHg; p? =?0.008)。透析前的细胞外水(ECW)显着降低了0.13?±?2.22 L(p?=?0.02)。不良事件没有显着增加(所有p≥0.05)。结论:这项研究表明,逐渐降低DNa可以显着降低透析前的IDWG,BP和ECW,而不会增加不良事件。需要进行大规模,交叉设计的研究来证明明确的因果关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号